Benchstrength is a New York City-based early-stage venture capital firm focused on investing in technology companies that transform business and uplift communities. The firm leads pre-seed and seed financing rounds across enterprise software, consumer, fintech, and healthcare sectors.
38% of their portfolio is in AI. Deal activity decreased year-over-year (3 deals in the last 12 months vs 5 prior). Their most common stage is series-a (46% of deals). Average disclosed round size is $16.7M (across 12 rounds with reported amounts).
Portfolio
11
Fund Size
$62M
Top Stage
Series A
Last 12 Mo
3
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
13 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Altis Labs | Series A | $25M | Sep 2026 |
| KKnox | Series A | $25M | Mar 2026 |
 Slide | Series B | $70M | Mar 2026 |
 Garage | Series A | $13.5M | Aug 2025 |
 Allspice | Series A | $15M | Jun 2025 |
| AAllspice.io | Series A | $15M | Jun 2025 |
 DevAI | Seed | $6M | Feb 2025 |
 Systole Health | Pre-Seed | $2M | Jan 2025 |
 Bolo AI | Seed | $8.1M | Jan 2025 |
| Altis Labs | Seed | $6M | Jun 2023 |
 The Folklore | Seed | — | — |
 Garage | Series A | $13.5M | — |
| DevAI | Pre-Seed | $1M | — |
Top Co-Investors
Wayfinder Ventures2 shared
Y Combinator2 shared
Initialized Capital2 shared
Infinity Ventures2 shared
FJ Labs2 shared
J-Ventures2 shared
Base10 Partners2 shared
Bowery Capital2 shared
DNX Ventures2 shared
private angel investors2 shared
GingerBread Capital2 shared
Rethink Impact2 shared
Flybridge Capital Partners2 shared
Root Ventures2 shared
The MBA Fund2 shared
L'ATTITUDE Ventures2 shared
OrbiMed2 shared
Debiopharm Innovation Fund2 shared
Pear VC2 shared
Slauson & Co.1 shared
Last updated: 20 October 2026